{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:07:12Z","timestamp":1764601632720,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81230014"],"award-info":[{"award-number":["81230014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470341","81370644"],"award-info":[{"award-number":["81470341","81370644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial","award":["Y14H080010","LQ13H080001","2014KYA069","2008C23047"],"award-info":[{"award-number":["Y14H080010","LQ13H080001","2014KYA069","2008C23047"]}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bbmt.2015.02.013","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T12:23:23Z","timestamp":1424435003000},"page":"1020-1028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Phenotypical and Functional Characterization of Bone Marrow Mesenchymal Stem Cells in Patients with Chronic Graft-versus-Host Disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Binsheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruxiu","family":"Tie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.02.013_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","article-title":"Chronic graft-versus-host disease","volume":"20","author":"Horwitz","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2015.02.013_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/bmt.2012.76","article-title":"Chronic GVHD: where are we? Where do we want to be? Will immunomodulatory drugs help?","volume":"48","author":"Linhares","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.013_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2015.02.013_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2010.05.011","article-title":"Consensus Conference on Clinical Practice in Chronic GVHD: second-line treatment of chronic graft-versus-host disease","volume":"17","author":"Wolff","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.013_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5500\/wjt.v3.i4.99","article-title":"Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies","volume":"3","author":"Cheuk","year":"2013","journal-title":"World J Transplant"},{"key":"10.1016\/j.bbmt.2015.02.013_bib6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V97.5.1196","article-title":"How I treat chronic graft-versus-host disease","volume":"97","author":"Vogelsang","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.013_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.clpt.6100301","article-title":"Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies","volume":"82","author":"Mimeault","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bbmt.2015.02.013_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molmed.2011.10.004","article-title":"The immunomodulatory capacity of mesenchymal stem cells","volume":"18","author":"Gebler","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.bbmt.2015.02.013_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2174\/1566524011313050016","article-title":"Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation","volume":"13","author":"Stagg","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.bbmt.2015.02.013_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2015.02.013_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2015.02.013_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3727\/096368910X564076","article-title":"Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells","volume":"20","author":"Crop","year":"2011","journal-title":"Cell Transplant"},{"key":"10.1016\/j.bbmt.2015.02.013_bib13","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","article-title":"Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice","volume":"106","author":"Eliopoulos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.013_bib14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3109\/14653240903121260","article-title":"Phenotypical\/functional characterization of in\u00a0vitro-expanded mesenchymal stromal cells from patients with Crohn's disease","volume":"11","author":"Bernardo","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2015.02.013_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/ard.2007.071233","article-title":"Phenotypical and functional characteristics of in\u00a0vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis","volume":"67","author":"Larghero","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bbmt.2015.02.013_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard.2007.076174","article-title":"Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis","volume":"67","author":"Kastrinaki","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bbmt.2015.02.013_bib17","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1089\/scd.2011.0447","article-title":"Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"21","author":"Li","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.bbmt.2015.02.013_bib18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/14653240903051558","article-title":"Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura","volume":"11","author":"Perez-Simon","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2015.02.013_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.013_bib20","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/stem.54","article-title":"Downregulation of APE1\/Ref-1 is involved in the senescence of mesenchymal stem cells","volume":"27","author":"Heo","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2015.02.013_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood.V56.2.289.289","article-title":"Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny","volume":"56","author":"Castro-Malaspina","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.013_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.yexcr.2007.11.021","article-title":"Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities","volume":"314","author":"Go","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bbmt.2015.02.013_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/scd.2008.0335","article-title":"Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells","volume":"18","author":"Liu","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.bbmt.2015.02.013_bib24","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1582-4934.2009.00912.x","article-title":"Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver","volume":"14","author":"Chen","year":"2010","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.bbmt.2015.02.013_bib25","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","article-title":"Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type","volume":"180","author":"Sasaki","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2015.02.013_bib26","first-page":"1421","article-title":"Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation","volume":"89","author":"Villaron","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.02.013_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e3181938998","article-title":"Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used","volume":"87","author":"Bartsch","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.02.013_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.exphem.2005.02.004","article-title":"Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation","volume":"33","author":"Rieger","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2015.02.013_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exphem.2010.01.006","article-title":"Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients","volume":"38","author":"Prata Kde","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2015.02.013_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000120440","article-title":"Sensitivity of mesenchymal stem cells and their progeny to medicines used for the treatment of hematoproliferative diseases","volume":"119","author":"Nifontova","year":"2008","journal-title":"Acta Haematol"},{"key":"10.1016\/j.bbmt.2015.02.013_bib31","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.exphem.2011.08.009","article-title":"The aging effect of chemotherapy on cultured human mesenchymal stem cells","volume":"39","author":"Buttiglieri","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2015.02.013_bib32","first-page":"1","article-title":"Chronic graft-versus-host disease: disease biology and novel therapeutic strategies","volume":"67","author":"Nishimori","year":"2013","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.bbmt.2015.02.013_bib33","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/stem.1432","article-title":"Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages","volume":"31","author":"Melief","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2015.02.013_bib34","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.4049\/jimmunol.1202996","article-title":"Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-gamma+CD4+ regulatory T cells to control transplant arteriosclerosis","volume":"190","author":"Hsu","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2015.02.013_bib35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1398-9995.2010.02509.x","article-title":"Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells","volume":"66","author":"Kavanagh","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.bbmt.2015.02.013_bib36","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.013_bib37","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2005-06-2529","article-title":"Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD","volume":"107","author":"Rieger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.013_bib38","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2011-06-362137","article-title":"Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation","volume":"118","author":"Kawano","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.013_bib39","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2003-06-2073","article-title":"Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells","volume":"103","author":"Clark","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.013_bib40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2141.2004.05108.x","article-title":"Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation","volume":"126","author":"Sanchez","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2015.02.013_bib41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3727\/000000007783472435","article-title":"Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats","volume":"16","author":"Wu","year":"2008","journal-title":"Cell Transplant"},{"key":"10.1016\/j.bbmt.2015.02.013_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: the devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbmt.2015.02.013_bib43","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/bmt.2010.195","article-title":"Mesenchymal stem cell as salvage treatment for refractory chronic GVHD","volume":"45","author":"Weng","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.013_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbmt.2009.11.006","article-title":"Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report","volume":"16","author":"Zhou","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.013_bib45","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.013_bib46","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/leu.2013.193","article-title":"Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells","volume":"27","author":"Geyh","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.02.013_bib47","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1182\/blood-2011-03-343467","article-title":"Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts","volume":"118","author":"Blau","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.013_bib48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/scd.2007.0008","article-title":"Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases","volume":"16","author":"Zhao","year":"2007","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.bbmt.2015.02.013_bib49","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1080\/10428190802455875","article-title":"Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patient with hematological malignant diseases","volume":"49","author":"Zhi-Gang","year":"2008","journal-title":"Leuk Lymphoma"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:12Z","timestamp":1761058272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1083879115001202"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.013","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypical and Functional Characterization of Bone Marrow Mesenchymal Stem Cells in Patients with Chronic Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}